甲苯咪唑
Mebendazole;(5-Benzoyl-1H-benzimidazol-2-yl)carbamicacidmethylester;(5-benzoyl-1h-benzimidazol-2-yl)-carbamicacidmethylester;(5-benzoyl-1h-benzimidazol-2-yl)-carbamicacimethylester;5-benzoyl-2-benzimidazolecarbamicacimethylester;bantenol;besantin;lomper;mbdz;5-benzoyl-1H-benzimidazol-2-yl carbamic acid methyl ester;5-benzoyl-2-benzimidazolecarbamic acid methyl ester;mebenvet;Mebex;methyl (5-benzoyl-1H-benzimidazol-2-yl)carbamate(SALTDATA: FREE);Methyl (5-benzoyl-1H-benzo[d]imidazol-2-yl)carbamate;Methyl [5-(Benzoyl)benzimidazol-2-yl]carbamate;noverme;telmin;vermox;methyl 5-benzoylbenzimidazol-2-ylcarbamate;5-Benzoyl-2-benzimidazolylcarbamic acid methyl ester;Methyl 5-benzoyl benzimidazole-2-carbamate;BSPBio_000233;BRD-K77987382-001-08-2;Mebendazol (INN-Spanish);NCGC00021698-06;Probes2_000149;MEBENDAZOLE [VANDF];MEBENDAZOLE [ORANGE BOOK];Mebendazol [INN-Spanish];Mebendazole, United States Pharmacopeia (USP) Reference Standard;MEBENDAZOLE [INN];Mebendazole,(S);DTXSID4040682;DB00643;AB00052203;Methyl N-(5-benzoyl-2-benzimidazolyl)carbamate;Pantelmin;(5-Benzoyl-1H-benzimidazol-2-yl)carbamic acid methyl ester;Mebendazole, European Pharmacopoeia (EP) Reference Standard;KBioSS_001778;Mebendazol;5-Benzoyl-2-benzimidazolecarbamic acid methyl ester;CHEBI:6704;SMR000036734;W-106901;SPBio_001442;MEBENDAZOLE [GREEN BOOK];P02CA01;V95;AS-12272;Telmin Equine Wormer;methyl 5-benzoyl-1H-benzo[d]imidazol-2-ylcarbamate;KBioGR_000712;HSDB 3232;MEBENDAZOLE (MART.);KBio2_004346;MEBENDAZOLE (EP MONOGRAPH);NS00008616;Z234895185;SPECTRUM1501110;NCGC00016806-07;Oprea1_768530;UNII-81G6I5V05I;HMS502F13;Besantin;HMS3604N11;methyl N-(6-benzoyl-1H-1,3-benzodiazol-2-yl)carbamate;Telmintic Powder;NCGC00021698-07;MLS006011879;Mebendazolum [INN-Latin];Mebendazolum (INN-Latin);Prestwick0_000217;Equivurmp Plus;Telmin Syringe Formula;HMS1921F03;HY-17595;Methyl 5-benzoyl-2-benzimidazolecarbamate;BRD-K77987382-001-06-6;Prestwick1_000217;NCGC00016806-13;Tox21_110620;Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester;BSPBio_003178;SR-01000003109;MEBENDAZOLE [USAN];Pharmakon1600-01501110;AKOS000539066;BPBio1_000257;HMS2095L15;Sufil;NSC 184849;5-Benzoyl-2-benzimidazolylcarbamicacidmethylester;Cambridge id 5250893;MEBENDAZOLE [USP MONOGRAPH];NCGC00016806-01;MEBENDAZOLE [EP MONOGRAPH];mebendazole;MEBENDAZOLE [JAN];Mebendazole for system suitability;CCG-39628;NCGC00016806-04;D70118;KBio1_000751;BIDD:GT0087;NCGC00016806-05;R-17635;HMS1536H11;Lomper;Mebendazole [USAN:USP:INN:BAN:JAN];N-(Benzoyl-5, benzimidazolyl)-2, carbamate de methyle [French];IDI1_000751;MEBENDAZOLE [USP-RS];AG-205/04588045;MEBENDAZOLE [USP IMPURITY];A820852;TimTec1_000869;Prestwick3_000217;Mebenoazole;CAS-31431-39-7;2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester (8CI);CPD000036734;Methyl N-(5-benzoyl-1H-benzimidazol-2-yl)carbamate;NCGC00016806-02;Vermirax;MEBENDAZOLE (USP IMPURITY);Spect...